Advertisements

Olazin

Quick links to important sections

Olazin

Advertisements

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Olazin

What is Olazin? Overview and Identity

Property Description
Active Ingredient Olanzapine
Form Tablet, Oral Disintegrating Tablet (ODT), Injection
Pharmacological Class Second-Generation Antipsychotic (Atypical)
General Purpose Psychological stability and balance
Origin Synthetic compound

Defining Olazin: Composition and Pharmacological Class

Olazin is a synthetic psychotropic agent centered on the single active ingredient, Olanzapine. The chemical structure of Olanzapine is classified as a thienobenzodiazepine derivative, representing a chemically distinct framework from older psychotropic agents. This single-ingredient compound is available in forms for both standard oral administration and for rapid-acting intramuscular injection, offering flexibility that is clinically recognized for managing acute situations.

Olazin is officially designated as a second-generation antipsychotic, a classification also referred to as an atypical antipsychotic. This medication is used to normalize brain activity by blocking receptors for the key neurotransmitters dopamine and serotonin, which is the mechanism supporting its role in mental health and helping to balance activity in the brain.

The General Purpose of Atypical Antipsychotics

As an atypical agent, the principal function of Olazin is to help restore equilibrium in the brain's communication network. By influencing multiple neuronal receptors, the medication is recognized for its ability to manage intense emotional states and temper disturbances in thought processes, thereby supporting psychological stability. The unique thienobenzodiazepine structure, combined with its dual action on serotonin and dopamine, is a differentiating factor that contributes to its broad therapeutic profile. This medication acts as a foundational element for individuals requiring consistent mental clarity and mood regulation.

Regulatory References

  1. NIH MedlinePlus
  2. European Medicines Agency (EMA)
  3. EMA
Advertisements

What side effects are possible with Olazin?

Olazin: Possible Side Effects and Safety Information

Safety Restrictions and Serious Risks

Olazin (olanzapine) carries a Boxed Warning regarding an increased risk of death in elderly patients with dementia-related psychosis; therefore, its use in this patient population is not recommended. This increased risk is often associated with cerebrovascular adverse events, such as stroke or transient ischemic attack.

Serious, but less common, risks include Neuroleptic Malignant Syndrome (NMS), a potentially fatal condition involving fever and severe muscle rigidity, and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), a severe hypersensitivity reaction that can involve multi-organ injury. There is also a risk of Tardive Dyskinesia, characterized by involuntary movements, typically of the face and tongue.

Adverse Reactions and Monitoring

Olazin is associated with significant metabolic changes, which necessitate regular monitoring of blood parameters. These include hyperglycemia and the development or worsening of diabetes mellitus (occasionally associated with ketoacidosis or coma), dyslipidemia (elevated cholesterol and triglycerides), and weight gain (very common). Complete blood counts must also be monitored, as the drug can rarely cause leukopenia or neutropenia (low white blood cell counts).

Other very common adverse reactions (affecting more than 1 in 10 people) include somnolence (sedation), increased appetite, and elevated liver enzymes (hepatic aminotransferases), which are usually transient. Common reactions (affecting up to 1 in 10 people) include dizziness, akathisia (restlessness), orthostatic hypotension (dizziness upon standing), constipation, and dry mouth.

Use requires caution in patients with a history of seizures, cardiovascular disease, or known QTc prolongation. Neonates exposed during the third trimester of pregnancy are at risk for drug withdrawal symptoms.

Advertisements

Overdose and Emergency Response

Olazin Overdose and When to Seek Help

This section describes official overdose information based on government regulatory documentation. Management of Olazin overdose requires immediate medical attention, as there is no specific antidote.

Documented Overdose Manifestations and Severe Outcomes

Feature Description (Strictly Regulatory/Label-Based)
Documented Presentations Symptoms include profound drowsiness, slurred speech, agitation, uncontrolled sudden movements, and progression to coma. Clinical signs often include a fast heartbeat (Tachycardia) and hypotension.
Severe Outcomes Overdose can lead to life-threatening complications such as seizures, Neuroleptic Malignant Syndrome (NMS), and serious cardiovascular effects like QTC prolongation or ventricular fibrillation.

Emergency Actions and Required Monitoring

Urgent medical help must be sought immediately in cases of suspected overdose. Regulatory documents state that you should call emergency services (e.g., 911) or a poison control helpline, particularly if the individual has collapsed, had a seizure, has trouble breathing, or can't be awakened.

Management is primarily symptomatic and supportive. This includes establishing and maintaining an airway and ensuring adequate oxygenation and ventilation. The official prescribing information notes that administration of activated charcoal can significantly reduce olanzapine exposure. Close medical supervision and monitoring must continue in a healthcare setting until all signs and symptoms of overdose have fully resolved.

Population Note: Elderly patients with dementia-related psychosis have a documented increased risk of death associated with the use of Olazin.

Advertisements

Therapeutic Uses of Olazin

The use of Olazin is generally applied in addressing symptoms related to systemic imbalance. The medication is commonly used for managing symptoms associated with schizophrenia (a condition affecting thought, feeling, and behavior) and bipolar I disorder (a condition involving periods of low and high mood).

The medication is relevant in conditions involving episodic or fluctuating manifestations. Olazin is used to help with symptoms associated with Schizophrenia, such as severe thought disturbances and perceptual changes, and is applied in addressing the extreme emotional tension and behavioral shifts of manic and mixed episodes in Bipolar I Disorder. It may also be part of symptomatic management for the depressive phase and is used in situations involving certain distressing symptoms, such as depression that has not fully responded to prior treatment (in combination).

“The therapeutic benefit supports patients during difficult episodes by easing distress and may assist with maintaining functional stability.”

Olazin is often used when symptoms become temporarily overwhelming and short-term symptomatic assistance is needed, such as during phases of acute agitation. It may assist with symptom clusters related to behavioral crises, providing supportive relief when symptoms interfere with daily functioning. The medication may also assist with easing symptoms related to systemic imbalance, such as severe nausea and vomiting in certain complex medical situations.

Quick Fact: Relief for Acute Agitation The medication is relevant for easing symptoms that become temporarily overwhelming, providing supportive relief in scenarios where short-term symptom stabilization is important.

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Eligibility Scope

The eligibility for using Olazin (olanzapine) is strictly defined by regulatory authorities and depends on age, pre-existing conditions, and physiological status.

Populations for Whom Use is Contraindicated

Use of Olazin is absolutely contraindicated in patients with a known hypersensitivity to olanzapine or any component of the formulation. A major restriction, subject to a Boxed Warning in the US, prohibits use in elderly patients with dementia-related psychosis due to a significant increase in mortality risk. The medicine is also contraindicated in patients with known risk of narrow-angle glaucoma.

Age-Related and Condition-Specific Eligibility Rules

Olazin is approved for use in adults (18 and older). In the US, it is approved for adolescents (13 and older) for specific conditions, while European regulations generally state that use is not recommended for children and adolescents under 18 years of age. Use requires caution in patients with a history of seizures or conditions that may lower the seizure threshold. Patients with moderate hepatic impairment may require a lower starting dose and careful monitoring, which defines their conditional eligibility. During the third trimester of pregnancy, use is limited, and breastfeeding is officially not recommended as the drug is excreted into breast milk.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Olazin's interaction profile is significantly determined by its metabolism, primarily via the CYP1A2 enzyme system. Concomitant use with CYP1A2 inhibitors, such as Fluvoxamine (a medication used for depression), can substantially increase Olazin concentrations in the blood, often necessitating a dose reduction of Olazin as specified in official labeling. Conversely, CYP1A2 inducers, like Carbamazepine and Tobacco smoking, can decrease Olazin concentrations, which may require monitoring and a possible dose increase.

A critical area for caution involves pharmacodynamic interactions with other centrally acting agents. Olazin may potentiate the effects of alcohol and other CNS depressants (e.g., benzodiazepines) due to additive sedative effects and the potential for increased orthostatic hypotension. Additionally, caution is required with other drugs that have anticholinergic effects.

Olazin may enhance the effect of antihypertensive agents and is known to antagonize the therapeutic effects of Levodopa and other dopamine agonists. Concomitant use with drugs known to prolong the QTc interval, such as Pimozide, carries an increased risk of cardiac rhythm abnormalities and is generally contraindicated or not recommended. The risk of bleeding may also be potentiated when Olazin is used alongside drugs that interfere with hemostasis, including NSAIDs and Warfarin.

Advertisements

Mechanism of Action

How Olazin Works

Olazin acts by engaging specific receptor- and enzyme-mediated signaling pathways. Its mechanism involves modulation of key transmitters and mediators that govern heightened or dysregulated physiological responses, resulting in an altered state of signaling equilibrium within targeted biological systems.


Receptor-Mediated Signaling Modulation

Olazin primarily exerts its influence by binding to and modulating activity at several key neuroreceptor subtypes. This action initiates or suppresses specific signaling sequences, impacting the flow of information across neural circuits and thus affecting systemic physiological parameters related to excitability and response coordination.


Enzyme-Targeted Cascade Restriction

The drug also engages mechanisms that involve the inhibition of specific enzymes central to inflammatory and cellular signaling cascades. By modifying these early molecular steps, Olazin restricts the magnitude of excessive mediator activity and alters the signaling equilibrium within pathways that may escalate under certain conditions.


Alteration of Dysregulated Physiological Signaling

Ultimately, Olazin’s combined effects on both receptor and enzyme mechanisms lead to alterations in the signaling dynamics of overactive or dysregulated physiological responses. This results in changes to physiological parameters via engagement of feedback mechanisms within affected pathways.

Advertisements

Dosage and Administration Information

How Olazin is Used: Official Administration and Dosing

Olazin (olanzapine) administration depends on the formulation and the goal of treatment. The medication is available through oral and intramuscular (IM) routes.


Administration Routes and Forms

Olazin is available in two primary forms with distinct uses:

  • Oral: Used for long-term stability and recurrence prevention. Available as standard Tablets (up to 20 mg) and Orally Disintegrating Tablets (ODT). Oral administration may be taken without regard to meals.
  • Intramuscular (IM) Injection: Used for the rapid management of acute agitation. The immediate-release injection (typically 10 mg per vial) must be administered deep into the muscle mass and is not to be given intravenously (IV) or subcutaneously (SC).

Standard Adult Dosing and Frequency

Oral treatment is generally administered on a once-daily schedule (QD). Doses are determined by the specific condition being managed:

Indication Starting Dose (Oral) Maximum Recommended Dose (Oral)
Schizophrenia 5 mg to 10 mg once daily 20 mg/day
Bipolar I Mania 10 mg or 15 mg once daily 20 mg/day

For acute IM use, subsequent injections (up to 10 mg) may be given, but the maximum total dose in a 24-hour period must not exceed 30 mg. Dose adjustments for oral formulations are typically made gradually, usually at intervals of not less than one week.


Population-Specific Considerations

A lower oral starting dose of 5 mg/day may be considered for specific patient groups, including older adults (aged 65 and over) and those with known hepatic impairment (reduced liver function).

Advertisements

Recent Clinical Evidence

Research Evidence and Overview of Studies for Olazin

This section provides an overview of the types of research studies that have been conducted for Olazin, describing the populations studied and the measured outcomes, without offering any clinical advice or making claims about personal results.

Evidence for Use in Schizophrenia (Including Symptom Maintenance)

Research for Olazin in schizophrenia included Randomized Controlled Trials (RCTs). These short-term studies were used in research exploring how symptoms change over time by comparing groups who received Olazin against groups who received an inactive placebo or another active treatment. Researchers primarily used standard symptom rating scales, such as the PANSS (Positive and Negative Syndrome Scale), to monitor the reported changes in symptom intensity or variability in adult populations during periods of increased symptom activity.

The findings from these acute studies described patterns related to measured changes in symptom scores. Following stabilization, other studies were conducted over longer defined time intervals to explore the use of Olazin in maintenance treatment. These maintenance trials were focused on monitoring outcomes reflecting daily functioning and calculating the time elapsed before symptoms were reported to return.

Evidence for Use in Bipolar I Disorder

Olazin was evaluated in research exploring acute manic or mixed episodes, which are conditions involving periods of heightened symptoms. The research examined outcomes capturing phases of heightened symptom activity, using scales like the YMRS (Young Mania Rating Scale) to measure scores related to episodic or acute changes.

Research for the depressive phase of Bipolar I Disorder examined Olazin in combination with Fluoxetine, a different type of medication, in short-term trials that measured changes in depressive symptom severity using specific rating scales (e.g., the HDRS).

What Research is Still Uncertain or Missing for Olazin

Studies focusing on long-term use are included in the evidence landscape, but the follow-up durations were limited in many core randomized, controlled trials. Therefore, the data describing use over many years are not fully established. Comparative evidence is lacking for many direct, head-to-head comparisons against all other available medications, which means that findings were mixed when trying to draw broad conclusions about differences in measured outcomes. Research is ongoing to address some of these limitations.

Key Studies & References

  1. Psychosis and schizophrenia in adults: prevention and management (NICE Guideline CG178)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Olazin (FAQ)

Q: What is the main reason Olazin is prescribed?

A: Regulatory documents indicate that Olazin is officially prescribed to treat schizophrenia. It is also approved for managing manic or mixed episodes associated with Bipolar I Disorder. The medication is used to support psychological stability and balance for these specific conditions.

Q: What does it mean that Olazin is a selective something?

A: Olazin is officially designated as an Atypical Antipsychotic, also known as a second-generation antipsychotic. This classification means it works by modulating activity at several key neuroreceptor subtypes, including dopamine and serotonin. This action helps to restore signaling equilibrium in the brain.

Q: How quickly does Olazin typically start working?

A: Studies indicate that the full therapeutic effect of the oral formulation may take time to develop. The medication often reaches a steady concentration in the blood within about one week of beginning a daily administration schedule. The intramuscular injection form, however, is designed for use in the rapid control of acute agitation.

Q: Does Olazin have a risk of addiction or dependence?

A: Official product information, including the drug abuse and dependence section, indicates a low risk for abuse or dependence. Regulatory sources, such as those from the UK, state that the medicine is not considered addictive.

Q: What happens if I forget to take Olazin?

A: Regulatory guidance for a missed dose is available and typically addresses the timing of taking the dose when remembered, or skipping it if the next scheduled dose is too near. This procedure is intended to help avoid taking doses too close together.

Q: Can Olazin be taken long-term?

A: The oral formulation of Olazin is used for long-term stability and recurrence prevention. Therefore, it is often taken for an extended period. Long-term use requires ongoing monitoring for potential metabolic changes, which includes checking blood glucose and lipid levels.

Q: Is Olazin a mood stabilizer or an antidepressant?

A: Olazin is officially designated as a Second-Generation (Atypical) Antipsychotic. It is approved for use in conjunction with other medicines, which may include mood stabilizers or antidepressants, for specific bipolar indications. Its primary classification is based on its mechanism of blocking dopamine and serotonin receptors.

Q: Are there any dietary restrictions when taking Olazin?

A: Oral Olazin can generally be taken without regard to meals. However, regulatory caution is advised regarding grapefruit consumption and certain substances that can affect how the drug is processed by the body. Smoking tobacco may also reduce the amount of the drug in the blood.

Q: Can I drink coffee while taking Olazin?

A: Official regulatory documents advise caution with substances that affect the CYP1A2 enzyme system. This enzyme is responsible for processing Olazin in the body, and its inhibition or induction by a substance could potentially change the concentration of the medication in the bloodstream.

Q: Why do doctors often prescribe a low dose to start?

A: The starting dose is often conservative, and dose increases are typically made gradually over time. This approach is used to manage potential side effects, such as orthostatic hypotension (dizziness upon standing), and helps optimize individual tolerance to the medication.

Q: Are there special considerations for taking Olazin if I have kidney problems?

A: Regulatory documents state that caution should be exercised in patients who have renal (kidney) impairment. Official documents note that a lower starting dose of the oral medication is a consideration for these patients.

Q: Does Olazin interact with birth control pills?

A: Regulatory information suggests that taking Olazin alongside estrogen-containing oral contraceptives may potentially increase the concentration of the drug in the blood. This effect is a documented interaction.

Q: Is it safe to take over-the-counter pain relievers with Olazin?

A: Caution is advised in regulatory materials regarding the concomitant use of Olazin with drugs that interfere with hemostasis (the body’s ability to stop bleeding). This specifically includes certain nonsteroidal anti-inflammatory drugs (NSAIDs) due to a potential for an increased risk of bleeding.

Q: Can Olazin affect my driving ability?

A: Regulatory warnings indicate that Olazin has the potential to cause cognitive and motor impairment. Due to common side effects such as somnolence (drowsiness) and dizziness, the medication may affect the ability to perform tasks like driving or operating machinery.

Q: Are the side effects of Olazin usually temporary?

A: Some side effects, such as the temporary elevation of liver enzymes, are often noted as transient (temporary) in official reports. However, other major risks like weight gain and metabolic changes are recognized as long-term effects that require ongoing monitoring.

Q: Is it possible for Olazin to stop working over time?

A: Regulatory studies for maintenance treatment focus on preventing the return of symptoms and calculate the time elapsed before symptoms were reported to return. This research acknowledges that the condition may relapse or the medication’s effect may diminish over time.

Q: What is the difference between Olazin and a sedative?

A: Olazin is officially designated as an Atypical Antipsychotic. While a common side effect is somnolence (sedation), this is a secondary effect. Its primary purpose is the modulation of dopamine and serotonin receptors for psychological stability.

Q: Can Olazin cause stomach issues like nausea or indigestion?

A: Yes, regulatory reports list common gastrointestinal side effects including constipation and dry mouth. Less common adverse reactions that have been reported include nausea, indigestion (dyspepsia), and stomach pain.

Q: Is it normal to have strange dreams when on Olazin?

A: Abnormal dreams have been reported as a common side effect for some formulations of the medicine, specifically in patients using the extended-release intramuscular injection. This is recognized in adverse reaction reports.

Q: What is the expected duration of treatment with Olazin?

A: The required duration of treatment is determined by the specific condition being managed. For the prevention of recurrence, the oral formulation is often used for long-term stability and maintenance of symptoms.

Q: Why do I need to be careful when stopping Olazin?

A: Regulatory documents state that abrupt discontinuation may rarely lead to acute symptoms such as sweating, insomnia, anxiety, tremor, nausea, or vomiting. Official instructions specify that gradual dose reduction is used to mitigate these effects.

Q: Can Olazin affect sexual function?

A: Changes in sexual function have been reported as side effects, including decreased libido. Official information also notes that Olazin is associated with elevated prolactin levels, which is a factor that can affect sexual function.

Q: Is Olazin available as a generic version?

A: Yes, the active ingredient in Olazin, known as Olanzapine, is available in generic formulations. These generic versions are available in addition to the branded versions of the medicine.

Q: Are there known interactions between Olazin and grapefruit?

A: Regulatory sources note that patients are cautioned about eating grapefruit or drinking grapefruit juice while taking the medicine. This suggests a potential interaction that requires caution.

Q: Is it typical to feel a flat emotion while on Olazin?

A: Adverse reaction reports include mentions of emotional changes. Less common side effects such as 'lack of feeling or emotion' or 'uncaring feelings' have been reported in some patients.

Q: What is the time window for taking my Olazin dose each day?

A: The oral formulation is generally administered on a once-daily (QD) schedule. Consistent daily administration is noted in official documents to maintain stable drug levels in the bloodstream.

Advertisements

How should Olazin be stored and disposed of?

Official Storage and Disposal Requirements

Olazin (olanzapine) must be stored and disposed of according to official regulatory documentation to ensure stability and safety.

Requirement Official Statement
Storage Temperature Store at Controlled Room Temperature (20 C to 25 C / 68 F to 77 F); Do not freeze the medicine.
Protection Keep the medicine in its original, tightly closed container and protect from light and moisture.
Stability The powder for injection must be used within 1 hour after reconstitution; discard any unused portion after this time.
Child Safety Keep out of the sight and reach of children at all times.
Disposal Disposal should utilize a drug take-back program. If unavailable, tablets should be mixed with an unappealing substance (like dirt or coffee grounds) and sealed before disposal in household trash; Do not flush the medicine.

These mandated conditions ensure the product remains stable and minimizes the risks associated with improper storage or environmental disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Olazin found in:

A-Z Index: